OPK Opko Health Inc

Price (delayed)

$1.475

Market cap

$1.03B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.35

Enterprise value

$1.36B

Opko Health Inc. is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and ...

Highlights
Opko Health's EPS has decreased by 40% from the previous quarter but it has increased by 10% YoY
The net income is down by 34% since the previous quarter but it is up by 13% year-on-year
The debt has increased by 49% YoY and by 32% QoQ
Opko Health's equity has decreased by 19% YoY and by 10% QoQ

Key stats

What are the main financial stats of OPK
Market
Shares outstanding
696.99M
Market cap
$1.03B
Enterprise value
$1.36B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.82
Price to sales (P/S)
1.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.7
Earnings
Revenue
$799.6M
EBIT
-$232.78M
EBITDA
-$128.11M
Free cash flow
-$56.36M
Per share
EPS
-$0.35
Free cash flow per share
-$0.08
Book value per share
$1.8
Revenue per share
$1.13
TBVPS
$1.08
Balance sheet
Total assets
$1.97B
Total liabilities
$721.21M
Debt
$408.77M
Equity
$1.25B
Working capital
$186.97M
Liquidity
Debt to equity
0.33
Current ratio
1.91
Quick ratio
0.92
Net debt/EBITDA
-2.6
Margins
EBITDA margin
-16%
Gross margin
32.6%
Net margin
-31.6%
Operating margin
-24.7%
Efficiency
Return on assets
-12.3%
Return on equity
-18%
Return on invested capital
-31.5%
Return on capital employed
-13.2%
Return on sales
-29.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPK stock price

How has the Opko Health stock price performed over time
Intraday
3.87%
1 week
-1.01%
1 month
15.23%
1 year
-17.13%
YTD
-2.32%
QTD
18%

Financial performance

How have Opko Health's revenue and profit performed over time
Revenue
$799.6M
Gross profit
$260.93M
Operating income
-$197.9M
Net income
-$252.43M
Gross margin
32.6%
Net margin
-31.6%
The net margin has decreased by 44% QoQ
OPK's operating margin is down by 36% since the previous quarter and by 22% year-on-year
The net income is down by 34% since the previous quarter but it is up by 13% year-on-year
The operating income has contracted by 26% from the previous quarter and by 7% YoY

Growth

What is Opko Health's growth rate over time

Valuation

What is Opko Health stock price valuation
P/E
N/A
P/B
0.82
P/S
1.3
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.7
Opko Health's EPS has decreased by 40% from the previous quarter but it has increased by 10% YoY
The P/B is 28% below the 5-year quarterly average of 1.1 and 12% below the last 4 quarters average of 0.9
Opko Health's equity has decreased by 19% YoY and by 10% QoQ
The company's revenue fell by 12% YoY and by 7% QoQ
The P/S is 10% below the 5-year quarterly average of 1.4 and 10% below the last 4 quarters average of 1.4

Efficiency

How efficient is Opko Health business performance
Opko Health's ROS has decreased by 47% from the previous quarter but it has increased by 17% YoY
The ROE has decreased by 41% QoQ
The ROA has contracted by 37% from the previous quarter but it has grown by 5% YoY
OPK's ROIC is up by 31% year-on-year but it is down by 28% since the previous quarter

Dividends

What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPK.

Financial health

How did Opko Health financials performed over time
The company's total assets is 174% higher than its total liabilities
Opko Health's current ratio has increased by 23% from the previous quarter and by 4.4% YoY
OPK's total liabilities is up by 17% year-on-year and by 16% since the previous quarter
The debt is 67% lower than the equity
The debt to equity has soared by 83% year-on-year and by 50% since the previous quarter
The debt has increased by 49% YoY and by 32% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.